Cargando…

Functional constipation masked as irritable bowel syndrome

BACKGROUND: Rome IV criteria for functional gastrointestinal disorders state that children suspected of having Irritable Bowel Syndrome (IBS) with Constipation (IBS-C) should be preliminarily treated for constipation. We aimed at verifying if functional constipation may indeed lead to an erroneous d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosto, Monica, D’Andrea, Paola, Salamone, Ignazio, Pellegrino, Salvatore, Costa, Stefano, Lucanto, Maria Cristina, Pallio, Socrate, Magazzu’, Giuseppe, Guandalini, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132980/
https://www.ncbi.nlm.nih.gov/pubmed/32252644
http://dx.doi.org/10.1186/s12876-020-01244-9
_version_ 1783517540155129856
author Tosto, Monica
D’Andrea, Paola
Salamone, Ignazio
Pellegrino, Salvatore
Costa, Stefano
Lucanto, Maria Cristina
Pallio, Socrate
Magazzu’, Giuseppe
Guandalini, Stefano
author_facet Tosto, Monica
D’Andrea, Paola
Salamone, Ignazio
Pellegrino, Salvatore
Costa, Stefano
Lucanto, Maria Cristina
Pallio, Socrate
Magazzu’, Giuseppe
Guandalini, Stefano
author_sort Tosto, Monica
collection PubMed
description BACKGROUND: Rome IV criteria for functional gastrointestinal disorders state that children suspected of having Irritable Bowel Syndrome (IBS) with Constipation (IBS-C) should be preliminarily treated for constipation. We aimed at verifying if functional constipation may indeed lead to an erroneous diagnosis of IBS with diarrhea (IBS-D) or IBS with mixed pattern of diarrhea and constipation (IBS-M). METHODS: We prospectively enrolled in an unblinded fashion 10 and 16 consecutive children referred to our center who met Rome IV criteria for a diagnosis of IBS-D and IBS-M, respectively. Patients who fulfilled criteria for suspect “occult constipation” were then given a bowel cleaning regimen with Polyethylene glycol 3350, re-evaluated at 2 months and followed up for at least 6 months. Sixteen additional patients with IBS with Constipation (IBS-C) referred in the same period served as control. The endpoints were: 1) a decrease of more than 50% in abdominal pain intensity and frequency scores; and 2) for patients with IBS-D and IBS-M: resolution of diarrhea. RESULTS: The endpoints were met by 8 (80%) and 14 (87%) of the patients with IBS-D and IBS-M, respectively, with decrease of abdominal pain and resolution of “diarrhea”. The response was not significantly different from that observed in 15 (93%) of the IBS-C control group. CONCLUSION: Acknowledging the limitations of the small number of patients and of the uncontrolled nature of the study, we suggest that a possibly large number of patients labeled as IBS-D or IBS-M may actually simply present functional constipation and should be managed as such.
format Online
Article
Text
id pubmed-7132980
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71329802020-04-11 Functional constipation masked as irritable bowel syndrome Tosto, Monica D’Andrea, Paola Salamone, Ignazio Pellegrino, Salvatore Costa, Stefano Lucanto, Maria Cristina Pallio, Socrate Magazzu’, Giuseppe Guandalini, Stefano BMC Gastroenterol Research Article BACKGROUND: Rome IV criteria for functional gastrointestinal disorders state that children suspected of having Irritable Bowel Syndrome (IBS) with Constipation (IBS-C) should be preliminarily treated for constipation. We aimed at verifying if functional constipation may indeed lead to an erroneous diagnosis of IBS with diarrhea (IBS-D) or IBS with mixed pattern of diarrhea and constipation (IBS-M). METHODS: We prospectively enrolled in an unblinded fashion 10 and 16 consecutive children referred to our center who met Rome IV criteria for a diagnosis of IBS-D and IBS-M, respectively. Patients who fulfilled criteria for suspect “occult constipation” were then given a bowel cleaning regimen with Polyethylene glycol 3350, re-evaluated at 2 months and followed up for at least 6 months. Sixteen additional patients with IBS with Constipation (IBS-C) referred in the same period served as control. The endpoints were: 1) a decrease of more than 50% in abdominal pain intensity and frequency scores; and 2) for patients with IBS-D and IBS-M: resolution of diarrhea. RESULTS: The endpoints were met by 8 (80%) and 14 (87%) of the patients with IBS-D and IBS-M, respectively, with decrease of abdominal pain and resolution of “diarrhea”. The response was not significantly different from that observed in 15 (93%) of the IBS-C control group. CONCLUSION: Acknowledging the limitations of the small number of patients and of the uncontrolled nature of the study, we suggest that a possibly large number of patients labeled as IBS-D or IBS-M may actually simply present functional constipation and should be managed as such. BioMed Central 2020-04-06 /pmc/articles/PMC7132980/ /pubmed/32252644 http://dx.doi.org/10.1186/s12876-020-01244-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tosto, Monica
D’Andrea, Paola
Salamone, Ignazio
Pellegrino, Salvatore
Costa, Stefano
Lucanto, Maria Cristina
Pallio, Socrate
Magazzu’, Giuseppe
Guandalini, Stefano
Functional constipation masked as irritable bowel syndrome
title Functional constipation masked as irritable bowel syndrome
title_full Functional constipation masked as irritable bowel syndrome
title_fullStr Functional constipation masked as irritable bowel syndrome
title_full_unstemmed Functional constipation masked as irritable bowel syndrome
title_short Functional constipation masked as irritable bowel syndrome
title_sort functional constipation masked as irritable bowel syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132980/
https://www.ncbi.nlm.nih.gov/pubmed/32252644
http://dx.doi.org/10.1186/s12876-020-01244-9
work_keys_str_mv AT tostomonica functionalconstipationmaskedasirritablebowelsyndrome
AT dandreapaola functionalconstipationmaskedasirritablebowelsyndrome
AT salamoneignazio functionalconstipationmaskedasirritablebowelsyndrome
AT pellegrinosalvatore functionalconstipationmaskedasirritablebowelsyndrome
AT costastefano functionalconstipationmaskedasirritablebowelsyndrome
AT lucantomariacristina functionalconstipationmaskedasirritablebowelsyndrome
AT palliosocrate functionalconstipationmaskedasirritablebowelsyndrome
AT magazzugiuseppe functionalconstipationmaskedasirritablebowelsyndrome
AT guandalinistefano functionalconstipationmaskedasirritablebowelsyndrome